10.1002/syn.20206 Synapse 166 SargentM.Goenaga-InfanteH.InagakiK.MaL.MeijaJ.PramannA.et al (2019)
Most patients lose the largest share in the first six months, then continue losing more slowly for several months before approaching a plateau
Regarding safety, the majority of reported adverse events were mild to moderate, ranging from 88% to 96%, depending on the specific study group
Learn about the study and its shortcomings -- in the Nutrafol section of our article about supplements and topical formulations for hair
Step 7: Initiate Therapy with Structured Monitoring Begin GLP-1 therapy with a clear, structured plan for monitoring progress and adjusting treatment as needed
Standard / Gradual Approach (3 mL = 3,333 mcg/mL) Reconstitute: Add 3.0 mL bacteriostatic water to the 10 mg combined vial 3,333 mcg/mL